Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $11.9 million.

  • Organogenesis Holdings' Change in Accured Expenses rose 62381.58% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 5921.52%. This contributed to the annual value of $9.2 million for FY2024, which is 19203.31% up from last year.
  • Organogenesis Holdings' Change in Accured Expenses amounted to $11.9 million in Q3 2025, which was up 62381.58% from -$5.9 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Change in Accured Expenses ranged from a high of $11.9 million in Q3 2025 and a low of -$8.0 million during Q1 2025
  • Over the past 5 years, Organogenesis Holdings' median Change in Accured Expenses value was $1.2 million (recorded in 2021), while the average stood at $413842.1.
  • Per our database at Business Quant, Organogenesis Holdings' Change in Accured Expenses plummeted by 40084.97% in 2022 and then soared by 62381.58% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Change in Accured Expenses (Quarter) stood at $2.6 million in 2021, then crashed by 400.85% to -$7.8 million in 2022, then skyrocketed by 35.28% to -$5.0 million in 2023, then soared by 165.11% to $3.3 million in 2024, then skyrocketed by 263.89% to $11.9 million in 2025.
  • Its Change in Accured Expenses stands at $11.9 million for Q3 2025, versus -$5.9 million for Q2 2025 and -$8.0 million for Q1 2025.